Latest Articles

Publication Date
Identification of BAY-439 - A Selective Human Phospholipase A2 Group V Inhibitor - Evotec

Identification of BAY-439 - A Selective Human Phospholipase A2 Group V Inhibitor Evotec

Published: June 5, 2026, 1:36 p.m.
"ePrescription" electronic system expands compensated list - Radio Moldova

"ePrescription" electronic system expands compensated list Radio Moldova

Published: June 5, 2026, 6:53 a.m.
Mixed reactions to $45.4bn South Australian health budget - Health Services Daily

Mixed reactions to $45.4bn South Australian health budget Health Services Daily

Published: June 5, 2026, 5:45 a.m.
AUDIO: Breast cancer patients react to planned drug withdrawal - Australian Broadcasting Corporation

AUDIO: Breast cancer patients react to planned drug withdrawal Australian Broadcasting Corporation

Published: June 5, 2026, 1:32 a.m.
Enhanced detection of vascularization in rectal endometriosis: A comparative study of microvascular flow and power Doppler.

Conventionally, rectal endometriotic nodules have been considered as poorly vascularized. However, new, more sensitive, Doppler techniques have been developed recently for assessing microvascularization. These new techniques might allow microvascularity in …

Published: June 5, 2026, midnight
Out of pocket expenditure incurred by couples seeking infertility services at tertiary level facilities in India.

Background and objectives Diagnosis and treatment of infertility, mostly sought at tertiary facilities, contribute to substantial out-of-pocket expenditure (OOPE). This study estimated OOPE among couples seeking care for endometriosis, male …

Published: June 5, 2026, midnight
Deep immune profiling of endometrial and peripheral blood cells in endometriosis.

How is endometrial and systemic immunity modulated throughout the menstrual cycle and are there changes in women with endometriosis?

Published: June 5, 2026, midnight
HEXACHLOROBENZENE AND CHLORPYRIFOS, ENVIRONMENTAL POLLUTANTS THAT DISRUPT THE ENDOCRINE SYSTEM, PROMOTE ANGIOGENESIS ASSOCIATED WITH ENDOMETRIOSIS.

Endometriosis defined by the growth of endometrial tissues outside the uterus, affects women of reproductive age. A critical process in endometriosis progression, angiogenesis involves endothelial cell migration, proliferation and tube …

Published: June 5, 2026, midnight
Gut microbiota dysbiosis in endometriosis: mechanistic insights and gut microbiota-targeted therapeutic strategies.

Endometriosis (EMs) is a prevalent, estrogen-dependent gynecological disorder characterized by the ectopic implantation and proliferation of endometrial-like tissue outside the uterine cavity, affecting approximately 10% of reproductive-aged women globally. Despite …

Published: June 5, 2026, midnight
Comparative post-marketing reporting signals of elagolix and myfembree in endometriosis: a FAERS pharmacovigilance study.

Elagolix and Myfembree are gonadotropin-releasing hormone (GnRH)-pathway therapies used for endometriosis, but their post-marketing safety reporting patterns remain incompletely characterized. Because spontaneous reporting databases are susceptible to reporting bias and …

Published: June 5, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!